Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank Bennett

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Nature Medicine|May 11, 2023
Personalized antisense oligonucleotides 'for free, for life' - the n-Lorem FoundationJoseph G Gleeson, C Frank Bennett, Jeffrey B Carroll, et al.
Clinical Pharmacology in Drug Development|August 16, 2022
Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus-Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple DosesKelong Han, Dickens Theodore, Gina McMullen, et al.
American Journal of Human Genetics|June 25, 2019
NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in MiceLaura Torres-Benito, Svenja Schneider, Roman Rombo, et al.
Cell Reports|September 30, 2016
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and MigrationSarah D Diermeier, Kung-Chi Chang, Susan M Freier, et al.
Human Molecular Genetics|June 5, 2015
DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHDJong-Won Lim, Lauren Snider, Zizhen Yao, et al.
Nucleic Acids Research|May 19, 2004
Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicingAndrew M Siwkowski, Leila Malik, Christine C Esau, et al.
Gene Therapy|January 25, 2022
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Nature Communications|March 28, 2026
Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular AtrophyTomoki Hirunagi, Kentaro Sahashi, Madoka Iida, et al.
Nucleic Acids Research|November 19, 2008
Potent inhibition of microRNA in vivo without degradationScott Davis, Stephanie Propp, Susan M Freier, et al.
Journal of Huntington'S Disease|July 27, 2014
Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's diseaseLisa M Stanek, Wendy Yang, Stuart Angus, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Nature Medicine|May 11, 2023
Personalized antisense oligonucleotides 'for free, for life' - the n-Lorem FoundationJoseph G Gleeson, C Frank Bennett, Jeffrey B Carroll, et al.
Clinical Pharmacology in Drug Development|August 16, 2022
Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus-Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple DosesKelong Han, Dickens Theodore, Gina McMullen, et al.
American Journal of Human Genetics|June 25, 2019
NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in MiceLaura Torres-Benito, Svenja Schneider, Roman Rombo, et al.
Cell Reports|September 30, 2016
Mammary Tumor-Associated RNAs Impact Tumor Cell Proliferation, Invasion, and MigrationSarah D Diermeier, Kung-Chi Chang, Susan M Freier, et al.
Human Molecular Genetics|June 5, 2015
DICER/AGO-dependent epigenetic silencing of D4Z4 repeats enhanced by exogenous siRNA suggests mechanisms and therapies for FSHDJong-Won Lim, Lauren Snider, Zizhen Yao, et al.
Nucleic Acids Research|May 19, 2004
Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicingAndrew M Siwkowski, Leila Malik, Christine C Esau, et al.
Gene Therapy|January 25, 2022
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres-Bérard, et al.
Nature Communications|March 28, 2026
Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular AtrophyTomoki Hirunagi, Kentaro Sahashi, Madoka Iida, et al.
Nucleic Acids Research|November 19, 2008
Potent inhibition of microRNA in vivo without degradationScott Davis, Stephanie Propp, Susan M Freier, et al.
Journal of Huntington'S Disease|July 27, 2014
Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's diseaseLisa M Stanek, Wendy Yang, Stuart Angus, et al.
Pageof 17